Aimfinity Investment CORP I Form 4 insider transactions

Aimfinity Investment Corp. I supplements its proxy statement with new independent director nominees and reports initial product shipments for Docter Inc.

Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination by two months, issuing a promissory note to its sponsor for funds used in the extensions.

Aimfinity Investment Corp. I has secured a fifth one-month extension to complete its business combination with Docter Inc., pushing the deadline to March 28, 2026, via a $500 promissory note from its sponsor's manager.

Aimfinity Investment Corp. I secured a one-month extension to complete its business combination with Docter Inc., pushing the deadline to February 28, 2026.

Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination with Docter Inc. by one month to January 28, 2026, through a $500 payment.

Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination with Docter Inc. to December 28, 2025, utilizing the first of nine possible monthly extensions.

Aimfinity Investment Corp. I has extended its deadline to complete the business combination with Docter Inc. to November 28, 2025, following shareholder approval and significant share redemptions.

Aimfinity Investment Corp. I shareholders approved charter amendments to extend its business combination deadline and remove the net tangible asset requirement, facilitating its merger with Docter Inc.

Aimfinity Investment Corp. I has terminated a prior securities purchase agreement and entered a new one to acquire Inkrock Holding Limited, aligning the transaction with its ongoing business combination with Docter Inc.

Aimfinity Investment Corp. I secured its final one-month extension to October 28, 2025, to complete its business combination with Docter Inc., funded by a $55,823.8 promissory note from its sponsor's designee.

Aimfinity Investment Corp. I has secured an eighth monthly extension to complete its business combination with Docter Inc., pushing the deadline to September 28, 2025, funded by a $55,823.8 promissory note from its sponsor's manager.

Aimfinity Investment Corp. I announced significant progress on its business combination with Docter Inc., securing new financing and extending the merger deadline to August 28, 2025.

Aimfinity Investment Corp. I has secured a one-month extension for its business combination with Docter Inc. until July 28, 2025, through a $55,823.8 promissory note from its sponsor's manager, I-Fa Chang.

Aimfinity Investment Corp. I (AIMUF) has filed an 8-K detailing the pro forma financial impact of its business combination with Docter Inc., revealing significant shareholder redemptions and the projected financial position of the combined entity, Inkwater Holding Inc.

Aimfinity Investment Corp. I has reached agreements with its underwriters to settle deferred commissions through a combination of cash and equity, while also revealing substantial shareholder redemptions impacting its pro forma equity ahead of its business combination with Docter Inc.

Aimfinity Investment Corp. I (AIMA) has extended its business combination deadline with Docter Inc. to June 28, 2025, facilitated by a $55,823.8 loan from its CEO, and acquired a Washington State property valued at $8.3 million from a CEO-controlled entity to support transaction financing, following its transition to OTC Markets.

Aimfinity Investment Corp. I will move its securities trading to the OTC Market on May 5, 2025, after receiving a delisting notice from Nasdaq due to non-compliance with listing standards.

Aimfinity Investment Corp. I (AIMA) will transition to the OTC Markets after failing to meet Nasdaq's business combination deadline, while also extending its deadline for a business combination with Docter Inc.

Aimfinity Investment Corp. I (AIMA) has entered into exchange agreements to convert outstanding notes into equity as part of the transaction financing for its business combination with Docter Inc.

Aimfinity Investment Corp. I's shareholders have approved the business combination with Taiwanese health technology company, Docter Inc.

Aimfinity Investment Corp. I's shareholders approved the business combination with Docter Inc., and the company extended the deadline for completion by one month to April 28, 2025.

Aimfinity Investment Corp. I and Docter Inc. have announced that the SEC has declared effective the registration statement for their business combination, marking a significant step towards the completion of the merger.

Aimfinity Investment Corp. I secures a one-month extension for its initial business combination by issuing a $55,823.8 promissory note to its sponsor.

Aimfinity Investment Corp. I (AIMAU) has amended the earnout structure of its proposed business combination with Docter Inc. and appointed Dr. Jonathan Tien to its post-merger board.

Aimfinity Investment Corp. I amends its merger agreement with Docter Inc., shifting the earnout milestones for additional share issuance to fiscal years 2025 and 2026 based on device sales targets.

Aimfinity Investment Corp. I extends its deadline for an initial business combination to February 28, 2025, by depositing $55,823.8 into its trust account.

Aimfinity Investment Corp. I has secured its ninth and final one-month extension to complete its initial business combination by depositing $60,000 into its trust account.

Aimfinity Investment Corp. I has extended its deadline to complete a business combination to December 28, 2024, by depositing $60,000 into its trust account.

Aimfinity Investment Corp. I extends its deadline for an initial business combination to November 28, 2024, with a $60,000 payment from its sponsor.

Aimfinity Investment Corp. I (AIMA) has entered into a backstop agreement and secured a working capital loan to ensure the minimum net tangible assets requirement for its business combination with Docter Inc. is met.